6 unknown, 4 completed. 10 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 10 | Unknown 6, Completed 4 |
Follow Pyrazinamide: new trials by email Literature Review of Pyrazinamide trials Research Report on Pyrazinamide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of an Oral Short-course Regimen Including Bedaquiline for the Treatment of Participants With Multidrug-resistant Tuberculosis in China Bedaquiline, Levofloxacin, Linezolid - Tuberculosis, Multidrug-Resistant | Phase 4 | Unknown | Beijing Chest Hospital | 212 | 2022-05-10 | 2023-01-18 |
| Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis Isoniazid, Rifampicin, Pyrazinamide - Tuberculosis, Pulmonary | Phase 4 | Unknown | Beijing Chest Hospital | 3900 | 2016-08-01 | 2017-03-20 |
| The Optimal Duration of Preoperative Anti-tuberculosis Treatment of Spinal Tuberculosis Isoniazid, Rifampicin, Ethambutol - Tuberculosis, Spinal | Phase 4 | Unknown | Beijing Chest Hospital | 400 | 2015-04-01 | 2015-06-23 |
| Systematic Empirical vs. Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating ART With CD4 Cell Counts <100/mm3 Xpert MTB/RIF®, Determine TB LAM, Chest X-ray, ART (Atripla, Truvada, Efavirenz, Combivir), Rifampin, isoniazid, pyrazinamide, ethambutol - HIV-1 Infection | Phase 4 | Completed | ANRS, Emerging Infectious Diseases | 1050 | 2014-09-01 | 2020-10-19 |
| Research on New Regimens for Retreatment Pulmonary Tuberculosis Isoniazid Aminosalicylate Tablets, Streptomycin injectable - Reinfection Pulmonary Tuberculosis | Phase 4 | Unknown | Shanghai Pulmonary Hospital, Shanghai, China | 864 | 2013-06-01 | 2015-01-06 |
| Evaluation of the Pharmacokinetics of Antituberculosis Drugs and Tuberculosis Treatment Outcomes Rifampicin, Isoniazid, Ethambutol, Pyrazinamide - AIDS With Tuberculosis | Phase 4 | Unknown | Makerere University | 400 | 2013-02-01 | 2015-04-13 |
| Reintroduction Regimens After Hepatitis During Anti-tuberculosis Treatment isoniazid, rifampin, pyrazinamide - Hepatitis, Tuberculosis, Pulmonary | Phase 4 | Unknown | National Taiwan University Hospital | 100 | 2011-07-01 | 2012-12-27 |
| Study of Safety and Efficacy of Different Regimes of Reintroduction of Anti-TB Drugs in Anti-TB Drugs Induced Liver Damage Rifampicin(max dose 10 mg/kg/day), Isoniazide (max dose 5 mg/kg/day) and Pyrazinamide (max dose 25 mg/kg/day) - Drug Induced Hepatotoxicity, Tuberculosis | Phase 4 | Completed | All India Institute of Medical Sciences | 175 | 2006-12-01 | 2012-02-16 |
| A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected Patients With Anergy isoniazid, rifampin + isoniazid, rifampin + pyrazinamide or not treatment - HIV Infections, Tuberculosis | Phase 4 | Completed | Sociedad Andaluza de Enfermedades Infecciosas | 332 | 1994-01-01 | 2008-10-24 |
| Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis isoniazid, rifampin + isoniazid or rifampin + pyrazinamide - HIV Infections | Phase 4 | Completed | Sociedad Andaluza de Enfermedades Infecciosas | 300 | 1994-01-01 | 2007-01-11 |
Tuberculosis (6) · Acquired Immunodeficiency Syndrome (2) · HIV Infections (2) · Tuberculosis, Pulmonary (2) · Chemical and Drug Induced Liver Injury (1) · Hepatitis (1) · Tuberculosis, Multidrug-Resistant (1) · Tuberculosis, Spinal (1)
Beijing Chest Hospital (3) · Sociedad Andaluza de Enfermedades Infecciosas (2) · ANRS, Emerging Infectious Diseases (1) · All India Institute of Medical Sciences (1) · Makerere University (1) · National Taiwan University Hospital (1) · Shanghai Pulmonary Hospital, Shanghai, China (1)
China (4) · Spain (2) · Uganda (2) · Cambodia (1) · Côte d’Ivoire (1) · India (1) · Taiwan (1) · Vietnam (1)
Antonio Rivero, MD PhD (2) · Felipes Diez, MD (2) · Fernando Lozano, MD PhD (2) · Jose Carlos Escribano, MD (2) · Juan Jose Hernandez, MD (2) · Juan Pasquau, MD (2) · Manuel Marquez, MD (2) · Rafael Castillo, MD (2) · Barbara Castelnuovo, MD, PhD (1) · Heping Xiao, M.D (1)
PMID 12809582, PMID 20156055, PMID 28399802, PMID 28629333, PMID 28928173, PMID 29162063, PMID 29514175, PMID 29519716, PMID 30910890, PMID 32558469, PMID 36883573, PMID 38561815, PMID 41925982